4
Changes in Ownership
Pyxis Oncology, Inc. Filed Acc 0000950170-25-048893
Options or other derivatives
- CFO & COO acquired 414,163 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Connealy Pamela Ann · CFO & COO
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-31 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +414,163 | $0.98 | $405,880 | 414,163 | D |
Loading xslF345X05/ownership.xml…